Tickwind
TodayOpportunitiesMarketsAI Chat
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

  • X
  • TelegramChinese
  • Newsletter

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • For writers
  • MCP server
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterFor writersMCP serverContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/CGEM/Capital expenditures

CULLINAN THERAPEUTICS, INC. (CGEM) Capital expenditures 2020–2025

CULLINAN THERAPEUTICS, INC. (CGEM) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.

$49,000FY2025 · since FY2020: $10,000 → $49,000
202122232425
Fiscal yearValueYoY
FY2025$49,000—
FY2024$0-100.0%
FY2023$208,000-81.6%
FY2022$1.1M—
FY2021$0-100.0%
FY2020$10,000—

Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.

Source: SEC XBRL filings · For reference only · Not investment advice

More CGEM financial trends

CGEM RevenueCGEM Net incomeCGEM Net marginCGEM Gross profitCGEM Gross marginCGEM Operating incomeCGEM Operating marginCGEM Operating cash flowCGEM Free cash flowCGEM Return on equityCGEM Stock buybacksCGEM Dividends paidCGEM Total assetsCGEM Total liabilitiesCGEM Shareholders’ equityCGEM overview →